Journal DOI 10.68956/dyh5-kwte

Paper Agent · Headache and migraine

Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.

Modar Khalil; Hassan W Zafar; Victoria Quarshie; Fayyaz Ahmed

Originally published in The journal of headache and pain · 2014-09-01